Cultivated Biosciences has successfully closed a $5 million seed funding round to advance its innovative yeast-derived cream, positioning itself to target the expanding dairy alternatives market.

Target Information

Cultivated Biosciences is a pioneering Swiss biotechnology startup specializing in the development of a patented yeast-derived cream designed to serve as a sustainable and healthier alternative to traditional dairy products. Founded in 2021 and based in Zurich, the company has transitioned from the research and development stage to preparing for market entry, with the aim of launching its innovative ingredient in the United States in 2025 and in Europe by 2026, subject to regulatory approvals.

The company’s yeast cream addresses existing shortcomings in the dairy-free sector that have left many consumers unsatisfied. By utilizing a unique fermentation process with a specific type of oleaginous yeast, Cultivated Biosciences produces a natural emulsion that can effectively mimic the texture, stability, and flavor of traditional dairy creams without compromising on health or sustainability.

Industry Overview in Switzerland

The dairy alternatives market globally is experiencing robust growth, particularly in Switzerland, where consumers are increasingly seeking out healthier and environmentally friendly options. In 202